Genetic Signatures in the Treatment of Stroke

E-ISSN： 1873-4286|21|3|343-354

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.3, 2015-01, pp. : 343-354

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetic Signatures in Ischemic Stroke: Focus on Aspirin Resistance

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 9, 2018-01 ,pp. : 974-982

Bentham Science Publishers

Access to resources Recommend Favorite

Antiplatelet Treatment in Ischemic Stroke Treatment

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 14, 2009-10 ,pp. : 1298-1316

Bentham Science Publishers

Access to resources Recommend Favorite

Tirofiban for the treatment of ischaemic stroke

By Bukow Simone C Daffertshofer Michael Hennerici Michael G

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 1, 2006-01 ,pp. : 73-79

Informa Healthcare

Access to resources Recommend Favorite

Genomic Signatures for Individualized Treatment of Malignant Tumors

Current Drug Discovery Technologies, Vol. 5, Iss. 1, 2008-03 ,pp. : 9-14

Bentham Science Publishers

Access to resources Recommend Favorite

Fibrinolytic treatment for acute ischaemic stroke

By Mazumdar Avi Derdeyn Colin P

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 3, 2006-02 ,pp. : 287-296

Informa Healthcare

Access to resources Recommend Favorite